Indigenous & Affordable HPV Vaccine
Quadrivalent Human Papillomavirus
(HPV Types 6, 11, 16, & 18) Vaccine (Recombinant)
(HPV Types 6, 11, 16, & 18) Vaccine (Recombinant)
0
nd
Cervical cancer is the 2nd most frequent
cancer among women in India.
0
%
83.2% of invasive cervical cancers are
attributed to HPV strains 16 or 18.
0
Lakh
Every year, an estimated 1,23,907 women are
diagnosed with cervical cancer
Source: WHO
HPV Vaccine
CERVAVAC® is India’s first indigenous and only gender-neutral qHPV vaccine, It is a quadrivalent HPV vaccine containing HPV types 6, 11, 16, and 18. Product developed through worldwide collaborative efforts.
Indication
CERVAVAC® is indicated in females 9 through 26 years of age for the prevention of cervical, vulvar, vaginal, and anal cancers caused by human papillomavirus (HPV) types 16, 18; cervical, vulvar, vaginal, and anal precancerous or dysplastic lesions caused by HPV types 6, 11, 16, 18; and genital warts caused by HPV types 6 and 11.
CERVAVAC® is indicated in males 9 through 26 years of age for the prevention of anal cancer caused by HPV types 16, 18; anal precancerous or dysplastic lesions caused by HPV types 6, 11, 16, 18; and genital warts caused by HPV types 6 and 11.
Symptoms
Genital warts
Flesh-colored bumps or clusters of
warts in the genital area
Abnormal Pap smear results
HPV infection can lead to changes in the cells
of the cervix
Plantar warts
Plantar warts are hard, grainy growths thatusually appear on the heels or balls of your feet cause discomfort.
Dosing Schedule
For individuals aged 9 to 14 years
CERVAVAC® should be administered according to a 2-dose schedule (0.5 ml at 0, 6 months).
For individuals aged 15 to 26 years
CERVAVAC® should be administered according to a 3-dose
(0.5 ml at 0, 2, 6 months) schedule.
The second dose should be administered at least one month after the first dose and the third dose should be administered at least 3 months after the second dose. All three doses should be given within a 1-year period.
Enquiry Now
